Literature DB >> 27775802

Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival.

Y-F Wang1, S Zhang, X-Q Li, Y Wang.   

Abstract

OBJECTIVE: To investigate Long non-coding RNA HULC (HULC) expression in cervical cancer and to evaluate its clinical significance. PATIENTS AND METHODS: HULC expression in 244 pairs of human cervical cancer and adjacent normal tissues was detected by real-time quantitative RT-PCR assay. The correlation between HULC and clinicopathological factors was also evaluated. The clinical and prognostic significance of HULC expression was analyzed statistically by Kaplan-Meier estimate and Cox regression model.
RESULTS: HULC expression was high in cervical cancer (p < 0.01). Also, the high HULC expression was significantly associated with the FIGO stage, lymph node metastasis and depth of cervical invasion (p < 0.05). Kaplan-Meier analysis showed that cervical cancer pa¬tients with high expression of HULC possessed poorer outcome than those with low expression of HULC (p < 0.001). Based on the univariate and multivariate analysis, the elevated expression of the HULC protein was a significant predictor of poor prognosis for cervical cancer patients (p = 0.001).
CONCLUSIONS: Our data firstly showed that the expression of HULC was upregulated in cervical cancer, and associated with overall survival, indicating that HULC may serve as a predictive biomarker for the prognosis of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27775802

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  Clinical important dysregulation of long non-coding RNA CCHE1 and HULC in carcinogenesis of cervical cancer.

Authors:  Neda Naghashi; Saeid Ghorbian
Journal:  Mol Biol Rep       Date:  2019-07-30       Impact factor: 2.316

2.  LncRNA expression and implication in osteosarcoma: a systematic review and meta-analysis.

Authors:  Ying Wang; Yuelong Huang; Peng Xiang; Wei Tian
Journal:  Onco Targets Ther       Date:  2017-11-09       Impact factor: 4.147

3.  Long Non-Coding RNA HULC Promotes Cervical Cancer Cell Proliferation, Migration and Invasion via miR-218/TPD52 Axis.

Authors:  Wenjun Lu; Xiaobin Wan; Limin Tao; Junhui Wan
Journal:  Onco Targets Ther       Date:  2020-02-05       Impact factor: 4.147

4.  Long noncoding RNA FTX is associated with prognosis of glioma patients.

Authors:  Yongjuan Liang; Hongzhen Lu
Journal:  J Gene Med       Date:  2020-06-21       Impact factor: 4.565

5.  Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.

Authors:  Shuqi Chi; Lina Shen; Teng Hua; Shuangge Liu; Guobing Zhuang; Xiaoxiao Wang; Xing Zhou; Guozhen Wang; Hongbo Wang
Journal:  Oncotarget       Date:  2017-05-31

6.  The prognostic value of long non coding RNAs in cervical cancer: A meta-analysis.

Authors:  Xiangrong Cui; Xuan Jing; Xueqing Wu
Journal:  Oncotarget       Date:  2017-05-04

7.  LINC00673 rs11655237 Polymorphism Is Associated With Increased Risk of Cervical Cancer in a Chinese Population.

Authors:  Yanhua Wang; Tianyou Luo
Journal:  Cancer Control       Date:  2018 Jan-Dec       Impact factor: 3.302

8.  FENDRR suppresses cervical cancer proliferation and invasion by targeting miR-15a/b-5p and regulating TUBA1A expression.

Authors:  Yunheng Zhu; Xiaohua Zhang; Lifeng Wang; Xiuxiang Zhu; Ziyin Xia; Ling Xu; Jun Xu
Journal:  Cancer Cell Int       Date:  2020-05-06       Impact factor: 5.722

9.  Long Non-Coding RNA HULC Promotes the Development of Breast Cancer Through Regulating LYPD1 Expression by Sponging miR-6754-5p.

Authors:  Nan Wang; Chaochao Zhong; Mingti Fu; Lin Li; Fang Wang; Pengwei Lv; Mingzhi Zhu; Youyi Xiong; Hailong Mi; Yuanting Gu
Journal:  Onco Targets Ther       Date:  2019-12-05       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.